检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:鲍蕾蕾[1] 苏羽[2] 陈海飞[1] 卞俊[1] 袁兵[1]
机构地区:[1]解放军第411医院药学科,上海200434 [2]江西中医学院,南昌330004
出 处:《中国药房》2013年第15期1351-1353,共3页China Pharmacy
基 金:全军医学科学技术研究"十二五"计划资助课题(No.CWS11J178);上海市卫生局青年科研项目(No.2009Y118)
摘 要:目的:研究复方灵芝孢子精油软胶囊(CGOC)对S180荷瘤小鼠的抗肿瘤作用。方法:通过皮下注射S180荷瘤小鼠腹水至小鼠右腋以复制小鼠实体瘤模型。实验分为模型对照(等容食用油)、环磷酰胺(75mg/kg)、灵芝孢子油(193mg/kg)与CGOC高、中、低剂量(1540、770、385mg/kg)组。灌胃给药,每天1次,连续10d。末次给药后颈椎脱臼处死大鼠,剥离肿瘤、胸腺、脾脏,称质量,计算抑瘤率与胸腺、脾脏指数;采用血液分析仪计数血液中白细胞、淋巴细胞的数量。结果:与模型对照组比较,CGOC高、中、低剂量组抑瘤率、白细胞总数显著升高(P<0.01或P<0.05);CGOC中剂量组胸腺指数、脾脏指数、淋巴细胞总数显著升高(P<0.01或P<0.05)。结论:CGOC能抑制S180荷瘤小鼠的肿瘤生长,并对免疫系统具有一定的保护作用。OBJECTIVE: To study anti-tumor effect of Compound Ganoderma lucidum spore oil soft capsule (CGOC) on S180 tumor-bearing mice. METHODS: The mice were inoculated with sarcoma S 180 ascites on right armpit and divided into six groups randomly: blank control group (constant volume of edible oil), cyclophosphamide group (75 mg/kg), G. lucidum spore oil group (193 mg/kg), CGOC high, medium and low-dose groups (1 540, 770 and 385 mg/kg). They were given medicine intragastrically once a day for consecutive 10 days. After last administration, the mice were sacrificed. The tumor, thymus and spleen were isolat- ed and weighted, and the inhibition rates of tumor and thymus and spleen index were calculated. The hematology analyzer was used to count the number of leukocytes and lymphocytes. RESULTS : Compared with model control group, the inhibition rate of tumor and the number of leukocytes in CGOC high, medium and low-dose groups increased significantly, and thymus, spleen index and the number of lymphocytes in CGOC mediumrdose group increased significantly (P(0.01 or P(0.05). CONCLUSION: CGOC could inhibit tumor erowth of S180 tumor-bearine mice and protect the immune system.
关 键 词:复方灵芝孢子精油软胶囊 荷瘤小鼠 抑瘤率 免疫器官指数
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3